Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Fast

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Veterinary Pathology|November 1, 1982
Renal lesions in MRL miceG J Kolaja, P E Fast
Journal of Clinical & Laboratory Immunology|February 1, 1982
Recovery of lymphocyte function after radiation therapy for cancer in relationship to prognosisJ A Stratton, P E Fast, I Weintraub
Toxicologic Pathology|January 1, 1985
Orally induced adjuvant-like arthritis in the ratJ E Gray, E R Larsen, P E Fast, et al.
Immunopharmacology|October 1, 1982
Membrane fluidity and cholesterol in thymus and spleen cells from mice treated with immunomodulatory drugsM V Merritt, N J Licht, C A Hatfield, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
HIV vaccine trials: some design issues including sample size calculationD O Dixon, W N Rida, P E Fast, et al.
Journal of Clinical Microbiology|February 3, 2000
Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trialT A Cha, K Kao, J Zhao, et al.
Immunopharmacology|December 1, 1982
Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levelsP E Fast, C A Hatfield, C L Franz, et al.
Vaccine|March 4, 2000
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic controlI M Longini, M E Halloran, A Nizam, et al.
The Pediatric Infectious Disease Journal|December 12, 2001
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.
Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Veterinary Pathology|November 1, 1982
Renal lesions in MRL miceG J Kolaja, P E Fast
Journal of Clinical & Laboratory Immunology|February 1, 1982
Recovery of lymphocyte function after radiation therapy for cancer in relationship to prognosisJ A Stratton, P E Fast, I Weintraub
Toxicologic Pathology|January 1, 1985
Orally induced adjuvant-like arthritis in the ratJ E Gray, E R Larsen, P E Fast, et al.
Immunopharmacology|October 1, 1982
Membrane fluidity and cholesterol in thymus and spleen cells from mice treated with immunomodulatory drugsM V Merritt, N J Licht, C A Hatfield, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
HIV vaccine trials: some design issues including sample size calculationD O Dixon, W N Rida, P E Fast, et al.
Journal of Clinical Microbiology|February 3, 2000
Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trialT A Cha, K Kao, J Zhao, et al.
Immunopharmacology|December 1, 1982
Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levelsP E Fast, C A Hatfield, C L Franz, et al.
Vaccine|March 4, 2000
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic controlI M Longini, M E Halloran, A Nizam, et al.
The Pediatric Infectious Disease Journal|December 12, 2001
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King, P E Fast, K M Zangwill, et al.
Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.
Pageof 2